Home Impaired anti-inflammatory function of apolipoprotein A-II concentrations predicts metabolic syndrome and diabetes at 4 years follow-up in elderly Turks
Article
Licensed
Unlicensed Requires Authentication

Impaired anti-inflammatory function of apolipoprotein A-II concentrations predicts metabolic syndrome and diabetes at 4 years follow-up in elderly Turks

  • Altan Onat , Gülay Hergenç , Erkan Ayhan , Murat Uğur and Günay Can
Published/Copyright: October 12, 2009

Abstract

Background: We evaluated prospectively the predictive value of serum apolipoprotein (apo) A-II, the second major apolipoprotein of high-density lipoprotein (HDL), for cardiometabolic risk in Turkish adults showing abnormalities in other proteins that normally confer protection.

Methods: Determinants of apoA-II and its associations with coronary heart disease (CHD), metabolic syndrome (MetS) and diabetes were investigated at 4 years follow-up in 193 elderly men and women.

Results: ApoA-II concentrations at baseline, in addition to being significantly related to HDL-cholesterol, were directly associated with complement C3 in multivariate linear regression analyses comprising nine variables. Following adjustment for gender, age and HDL-cholesterol (>30/>33 g/L, in men and women, respectively), low serum apoA-II concentrations predicted incident MetS [relative risk (RR) 3.5 (95% CI 1.4; 8.6)] and type 2 diabetes [RR 4.5 (95% CI 1.3; 15.6)] in both genders at an increment of 1 SD. Increased apoA-II values were not associated with prevalent or incident CHD, and tended to be marginally atheroprotective only in males.

Conclusions: Serum apoA-II concentrations confer risk for MetS and diabetes and exhibit evidence of anti-inflammatory properties among Turks. These findings support the effects seen for several other HDL protein constituents. This finding may explain the increased cardiometabolic risk among Turks.

Clin Chem Lab Med 2009;47:1389–94.


Corresponding author: Prof. Dr. Altan Onat, Nisbetiye cad. 59/24, Etiler 34335, İstanbul, Turkey Phone: +90 212 351 6217, Fax: +90 212 351 4235,

Received: 2009-6-18
Accepted: 2009-7-24
Published Online: 2009-10-12
Published in Print: 2009-11-01

©2009 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editorial
  2. The journal impact factor: navigating between Scylla and Charybdis
  3. Opinion Papers
  4. Journal Impact Factor: it will go away soon
  5. The Journal Impact Factor: don't expect its demise any time soon
  6. Reviews
  7. Discordant total and free prostate-specific antigen (PSA) assays: does calibration with WHO reference materials diminish the problem?
  8. Molecular diagnostics in acute leukemias
  9. Opinion Paper
  10. Considerations for the development of a reference method for sequencing of haploid DNA – an opinion paper on behalf of the IFCC Committee on Molecular Diagnostics. International Federation of Clinical Chemistry and Laboratory Medicine
  11. General Clinical Chemistry and Laboratory Medicine
  12. Meta-analyses of diagnostic studies
  13. Development and implementation of an automatic system for verification, validation and delivery of laboratory test results
  14. Comparison of visual vs. automated detection of lipemic, icteric and hemolyzed specimens: can we rely on a human eye?
  15. Prevalence of thyroid autoimmunity and subclinical hypothyroidism in persons with chronic kidney disease not requiring chronic dialysis
  16. Serum albumin fragmentation in end-stage renal disease patients – a pilot study
  17. Enhanced bone metabolism in vegetarians – the role of vitamin B12 deficiency
  18. Impaired anti-inflammatory function of apolipoprotein A-II concentrations predicts metabolic syndrome and diabetes at 4 years follow-up in elderly Turks
  19. Detection of myelin autoantibodies: evaluation of an assay system for diagnosis of multiple sclerosis in differentiation from other central nervous system diseases
  20. The rate of manual peripheral blood smear reviews in outpatients
  21. Markers of infection in inpatients and outpatients with acute Q-fever
  22. Validation and Outcome Studies
  23. Potential utility of the new Sysmex XE 5000 red blood cell extended parameters in the study of disorders of iron metabolism
  24. A new turbidimetric method for assaying serum C-reactive protein based on phosphocholine interaction
  25. Potential of the Sebia Capillarys® neonat fast automated system for neonatal screening of sickle cell disease
  26. Biochemical role of intravaginal sildenafil citrate as a novel antiabortive agent in unexplained recurrent spontaneous miscarriage: first clinical study of four case reports from Egypt
  27. Cancer Diagnostics
  28. Hypoxia related growth factors and p53 in preoperative sera from patients with colorectal cancer – evaluation of the prognostic significance of these agents
  29. Letters to the Editor
  30. Quick and easy colorimetric test for calibration control of liquid handling workstations
  31. GSTP1*B allele increases the risk for asthma in children
Downloaded on 5.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2009.310/html
Scroll to top button